AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 273: H1611-H1618, 1997;
0363-6135/97 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, Y. Y.
Right arrow Articles by Xiao, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, Y. Y.
Right arrow Articles by Xiao, R. P.

AJP - Heart and Circulatory Physiology, Vol 273, Issue 3 1611-H1618, Copyright © 1997 by American Physiological Society


ARTICLES

Localized cAMP-dependent signaling mediates beta 2-adrenergic modulation of cardiac excitation-contraction coupling

Y. Y. Zhou, H. Cheng, K. Y. Bogdanov, C. Hohl, R. Altschuld, E. G. Lakatta and R. P. Xiao
Laboratory of Cardiovascular Science, National Institute on Aging, Baltimore, Maryland 21224, USA.

Recent studies have shown that beta 2-adrenergic receptor (beta 2-AR)-stimulated increases in the intracellular Ca2+ (Cai) transient and contraction in cardiac myocytes are dissociated from the increase in adenosine 3',5'-cyclic monophosphate (cAMP) level and are not accompanied by an increase in phospholamban phosphorylation, an acceleration in relaxation, or a reduction in myofilament Ca2+ response. Thus we hypothesized that the beta 2-AR modulation of cardiac excitation-contraction (EC) coupling may be mediated by either a cAMP-independent mechanism or a compartmentalized cAMP pathway. To directly distinguish between these two possibilities, the responses of the L-type Ca2+ current (ICa), Cai transient, and contraction to beta 2-AR as well as to beta 1-AR stimulation were examined in rat ventricular myocytes in the presence or absence of specific inhibitory cAMP analogs, Rp diastereomers of adenosine 3',5'-cyclic monophosphothioate (Rp-cAMPS) and 8-(4-chlorophenylthio)-cAMP (Rp-CPT-cAMPS). As expected, the positive inotropic effect induced by an adenylyl cyclase activator, forskolin (2 x 10(-7) M), or a beta 1-AR agonist, norepinephrine (5 x 10(-8) M) plus prazosin (10(-6) M), was completely blocked by Rp-CPT-cAMPS. More importantly, the responses of ICa, Cai transient, and contraction to beta 2-AR stimulation by zinterol (10(-5) M) or isoproterenol plus a selective beta 1-AR antagonist, CGP-20712A, were also entirely abolished by Rp-cAMPS (in the patch-pipette solution) or Rp-CPT-cAMPS (in the bath solution). In pertussis toxin-treated cells, although the response of cAMP was not altered, the beta 2-AR-stimulated increase in contraction amplitude was markedly enhanced and accompanied by a hastened relaxation, resulting in a tight association between cAMP and contraction. These results indicate that beta 2-AR modulation of cardiac excitation-contraction coupling requires cAMP. The dissociation of beta 2-AR-stimulated cAMP production and regulation of myofilament and sarcoplasmic reticulum functions is attributable to a functional compartmentation of the cAMP-dependent signaling due to an activation of beta 2-AR-coupled Gi and/or G(o).


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. M. Ecker, C.-C. Lin, J. Powers, B. K. Kobilka, A. M. Dubin, and D. Bernstein
Effect of targeted deletions of {beta}1- and {beta}2-adrenergic-receptor subtypes on heart rate variability
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H192 - H199.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W.-Z. Zhu, K. Chakir, S. Zhang, D. Yang, C. Lavoie, M. Bouvier, T. E. Hebert, E. G. Lakatta, H. Cheng, and R.-P. Xiao
Heterodimerization of {beta}1- and {beta}2-Adrenergic Receptor Subtypes Optimizes {beta}-Adrenergic Modulation of Cardiac Contractility
Circ. Res., August 5, 2005; 97(3): 244 - 251.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Xiang, E. Devic, and B. Kobilka
The PDZ Binding Motif of the beta 1 Adrenergic Receptor Modulates Receptor Trafficking and Signaling in Cardiac Myocytes
J. Biol. Chem., September 6, 2002; 277(37): 33783 - 33790.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Gong, H. Sun, W. J. Koch, T. Rau, T. Eschenhagen, U. Ravens, J. F. Heubach, D. L. Adamson, and S. E. Harding
Specific {beta}2AR Blocker ICI 118,551 Actively Decreases Contraction Through a Gi-Coupled Form of the {beta}2AR in Myocytes From Failing Human Heart
Circulation, May 28, 2002; 105(21): 2497 - 2503.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
M. Zaugg, M. C. Schaub, T. Pasch, and D. R. Spahn
Modulation of {beta}-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action
Br. J. Anaesth., January 1, 2002; 88(1): 101 - 123.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. Devic, Y. Xiang, D. Gould, and B. Kobilka
beta -Adrenergic Receptor Subtype-Specific Signaling in Cardiac Myocytes from beta 1 and beta 2 Adrenoceptor Knockout Mice
Mol. Pharmacol., September 1, 2001; 60(3): 577 - 583.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Z.-S. Zhang, H.-J. Cheng, T. Ukai, H. Tachibana, and C.-P. Cheng
Enhanced Cardiac L-Type Calcium Current Response to beta 2-Adrenergic Stimulation in Heart Failure
J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 188 - 196.
[Abstract] [Full Text]


Home page
Anesth. Analg.Home page
G. M. Janelle, F. Urdaneta, M. L. Blas, J. Shryock, Y.-S. Tang, T. D. Martin, and E. B. Lobato
Inhibition of Phosphodiesterase Type III Before Aortic Cross-Clamping Preserves Intramyocardial Cyclic Adenosine Monophosphate During Cardiopulmonary Bypass
Anesth. Analg., June 1, 2001; 92(6): 1377 - 1383.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R.-P. Xiao
Cell Logic for Dual Coupling of a Single Class of Receptors to Gs and Gi Proteins
Circ. Res., October 13, 2000; 87(8): 635 - 637.
[Full Text] [PDF]


Home page
Circ. Res.Home page
J. D. Kilts, M. A. Gerhardt, M. D. Richardson, G. Sreeram, G. B. Mackensen, H. P. Grocott, W. D. White, R. D. Davis, M. F. Newman, J. G. Reves, et al.
{beta}2-Adrenergic and Several Other G Protein-Coupled Receptors in Human Atrial Membranes Activate Both Gs and Gi
Circ. Res., October 13, 2000; 87(8): 705 - 709.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Nagykaldi, D. Kem, R. Lazzara, and B. Szabo
Conditioning of beta 1-adrenoceptor effect via beta 2-subtype on L-type Ca2+ current in canine ventricular myocytes
Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1329 - H1337.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Zaugg, W. Xu, E. Lucchinetti, S. A. Shafiq, N. Z. Jamali, and M. A. Q. Siddiqui
{beta}-Adrenergic Receptor Subtypes Differentially Affect Apoptosis in Adult Rat Ventricular Myocytes
Circulation, July 18, 2000; 102(3): 344 - 350.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Q. He, G. Wu, and M. C. Lapointe
Isoproterenol and cAMP regulation of the human brain natriuretic peptide gene involves Src and Rac
Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E1115 - E1123.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. S. Ostrom, J. D. Violin, S. Coleman, and P. A. Insel
Selective Enhancement of beta -Adrenergic Receptor Signaling by Overexpression of Adenylyl Cyclase Type 6: Colocalization of Receptor and Adenylyl Cyclase in Caveolae of Cardiac Myocytes
Mol. Pharmacol., May 1, 2000; 57(5): 1075 - 1079.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
R.-P. Xiao, H. Cheng, Y.-Y. Zhou, M. Kuschel, and E. G. Lakatta
Recent Advances in Cardiac {beta}2-Adrenergic Signal Transduction
Circ. Res., November 26, 1999; 85(11): 1092 - 1100.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. F. Steinberg
The Molecular Basis for Distinct {beta}-Adrenergic Receptor Subtype Actions in Cardiomyocytes
Circ. Res., November 26, 1999; 85(11): 1101 - 1111.
[Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y.-Y. Zhou, H. Cheng, L.-S. Song, D. Wang, E. G. Lakatta, and R.-P. Xiao
Spontaneous beta 2-Adrenergic Signaling Fails To Modulate L-Type Ca2+ Current in Mouse Ventricular Myocytes
Mol. Pharmacol., September 1, 1999; 56(3): 485 - 493.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
N. Dzimiri
Regulation of beta -Adrenoceptor Signaling in Cardiac Function and Disease
Pharmacol. Rev., September 1, 1999; 51(3): 465 - 502.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Kuschel, Y.-Y. Zhou, H. Cheng, S.-J. Zhang, Y. Chen, E. G. Lakatta, and R.-P. Xiao
Gi Protein-mediated Functional Compartmentalization of Cardiac beta 2-Adrenergic Signaling
J. Biol. Chem., July 30, 1999; 274(31): 22048 - 22052.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. W. Dorn II, N. M. Tepe, J. N. Lorenz, W. J. Koch, and S. B. Liggett
Low- and high-level transgenic expression of beta 2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galpha q-overexpressing mice
PNAS, May 25, 1999; 96(11): 6400 - 6405.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. G. Vila-Petroff, A. Younes, J. Egan, E. G. Lakatta, and S. J. Sollott
Activation of Distinct cAMP-Dependent and cGMP-Dependent Pathways by Nitric Oxide in Cardiac Myocytes
Circ. Res., May 14, 1999; 84(9): 1020 - 1031.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Kuschel, Y.-Y. Zhou, H. A. Spurgeon, S. Bartel, P. Karczewski, S.-J. Zhang, E.-G. Krause, E. G. Lakatta, and R.-P. Xiao
ß2-Adrenergic cAMP Signaling Is Uncoupled From Phosphorylation of Cytoplasmic Proteins in Canine Heart
Circulation, May 11, 1999; 99(18): 2458 - 2465.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Pavoine, S. Magne, A. Sauvadet, and F. Pecker
Evidence for a beta 2-Adrenergic/Arachidonic Acid Pathway in Ventricular Cardiomyocytes. REGULATION BY THE beta 1-ADRENERGIC/cAMP PATHWAY
J. Biol. Chem., January 8, 1999; 274(2): 628 - 637.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Zheng, S.-J. Zhang, W.-Z. Zhu, B. Ziman, B. K. Kobilka, and R.-P. Xiao
beta 2-Adrenergic Receptor-induced p38 MAPK Activation Is Mediated by Protein Kinase A Rather than by Gi or Gbeta gamma in Adult Mouse Cardiomyocytes
J. Biol. Chem., December 15, 2000; 275(51): 40635 - 40640.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. G. Vila Petroff, J. M. Egan, X. Wang, and S. J. Sollott
Glucagon-Like Peptide-1 Increases cAMP but Fails to Augment Contraction in Adult Rat Cardiac Myocytes
Circ. Res., August 31, 2001; 89(5): 445 - 452.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online